The impact of COVID-19 on deaths from dementia and Alzheimer's disease in Chile: an analysis of panel data for 16 regions, 2017–2022

dc.contributor.affiliationUniversidad San Sebastian
dc.contributor.affiliationUniversidad de Concepcion
dc.contributor.affiliationUniversidad de Las Americas - Chile
dc.contributor.authorBarria-Sandoval, Claudia
dc.contributor.authorFerreira, Guillermo
dc.contributor.authorNavarrete, Jean Paul
dc.contributor.authorFarhang, Maryam
dc.date.accessioned2025-04-24T16:31:39Z
dc.date.available2025-04-24T16:31:39Z
dc.date.issued2024-05
dc.description.abstractBackground Although several studies have documented the detrimental impacts of global COVID-19 containment measures on individuals with Alzheimer ' s disease and dementia, a comprehensive analysis of mortality rates for these conditions within the Chilean population is notably lacking. This study aimed to analyze the impact of COVID-19 on mortality rates among individuals with dementia and Alzheimer ' s disease in Chile. Methods A retrospective longitudinal cross-sectional study was conducted, considering mortality data for speci fi c mental health conditions during the pre -pandemic and pandemic contexts of COVID-19 in Chile. Quantile regression techniques were employed to analyze the existence of differences between the two periods, while nonobservable heterogeneity models for panel data methods were used to evaluate the effect of COVID-19 mortality on crude mortality rates. Findings Statistically signi fi cant differences were observed in the number of deaths from dementia and Alzheimer ' s disease between the pre -pandemic and COVID-19 pandemic periods. Speci fi cally, crude mortality rates decreased by 10% ( - 0.10 [95% CI: - 0.16, - 0.05]) during the pandemic period. Furthermore, the number of deaths from COVID-19 during the pandemic period has a very weak incidence of deaths from mental health conditions such as dementia and Alzheimer ' s. Speci fi cally, a unit percentage increase in con fi rmed cases from COVID-19 would result in a 7% ( - 0.07 [95% CI: - 0.13, - 0.001]) decrease in the number of deaths from dementia and Alzheimer ' s. These fi ndings are supported by the application of panel regression with one-way random effects models. Interpretation The study fi ndings indicate a reduction in mortality rates attributed to dementia and Alzheimer ' s disease during the COVID-19 pandemic in Chile. This decline could be attributed to the potential underreporting of mental illness as the cause of death during the pandemic period. Several studies have highlighted that approximately 30% of death certi fi cates fail to document the presence of a dementia syndrome. Moreover, the cause of death recorded for individuals with mental health conditions may be in fl uenced by the physician ' s familiarity with the patient or re fl ect the prevailing approach to managing end -stage dementia patients.
dc.format.mimetypeapplication/pdf
dc.identifier.citationThe Lancet Regional Health - Americas, 33, 100726. https://doi.org/10.1016/j.lana.2024.100726
dc.identifier.doihttps://doi.org/10.1016/j.lana.2024.100726
dc.identifier.issn2667-193X
dc.identifier.orcidhttps://orcid.org/0000-0002-7233-9885
dc.identifier.orcidhttps://orcid.org/0000-0001-5060-6199
dc.identifier.orcidhttps://orcid.org/0000-0001-7067-7373
dc.identifier.orcidhttps://orcid.org/0000-0001-6345-6329
dc.identifier.pmid38584874
dc.identifier.researcheridLJL-3555-2024
dc.identifier.researcheridKYR-5364-2024
dc.identifier.researcheridJBJ-2676-2023
dc.identifier.rorhttps://ror.org/04jrwm652
dc.identifier.rorhttps://ror.org/0460jpj73
dc.identifier.rorhttps://ror.org/01c080z51
dc.identifier.rorhttps://ror.org/0166e9x11
dc.identifier.rorhttps://ror.org/012pnb193
dc.identifier.scopusauthorid57222059380
dc.identifier.scopusauthorid54395216900
dc.identifier.scopusauthorid56536233700
dc.identifier.scopusauthorid57205684088
dc.identifier.urihttps://repositorio.udla.cl/handle/udla/1846
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.isindexedbyWeb of Science
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://www.elsevier.com/tdm/userlicense/1.0/
dc.sourceThe Lancet Regional Health - Americas
dc.source.urihttps://www.sciencedirect.com/science/article/pii/S2667193X2400053X
dc.subjectAlzheimer ' s disease
dc.subjectCOVID-19
dc.subjectChronic diseases
dc.subjectDementia
dc.subjectMental health
dc.subjectMortality
dc.subject.lcshEnfermedad de Alzheimer
dc.subject.lcshEnfermedades crónicas
dc.subject.lcshCOVID-19 (Enfermedad)
dc.subject.lcshDemencia
dc.subject.lcshSalud mental
dc.subject.lcshMortalidad
dc.subject.oecd13 Ciencias Médicas y de la Salud
dc.subject.oecd23.3 Ciencias de la Salud
dc.titleThe impact of COVID-19 on deaths from dementia and Alzheimer's disease in Chile: an analysis of panel data for 16 regions, 2017–2022
dc.title.alternativeThe impact of COVID-19 on deaths from dementia and Alzheimer’s disease in Chile: an analysis of panel data for 16 regions, 2017–2022
dc.title.alternativeThe impact of COVID-19 on deaths from dementia and Alzheimer's disease in Chile: an analysis of panel data for 16 regions, 2017-2022
dc.title.alternativeThe impact of COVID-19 on deaths from dementia and Alzheimer's disease in Chile: an analysis of panel data for 16 regions, 2017-2022.
dc.typejournal article
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
oaire.citation.titleThe Lancet Regional Health - Americas
oaire.citation.volume33
udla.curacion.controljmvg
udla.odsODS 3: Salud y bienestar
udla.oecd.area3 Ciencias Médicas y de la Salud
udla.oecd.subarea3.3 Ciencias de la Salud

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
183-The impact of COVID.pdf
Size:
985.89 KB
Format:
Adobe Portable Document Format
Description:
Artículo

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections